SlideShare a Scribd company logo
Development of Nutraceuticals & functional foods
Contents 
1. Introduction 
2. Relationship between Nutraceuticals and other 
health products 
3. Nutraceuticals 
 Major Nutraceuticals: manufacture, source and use 
 Demographic trends for use of Nutraceutical supplements 
4. Functional Foods 
 FF development 
 Probiotics 
 Prebiotics 
 Functional drinks 
 Functional cereals 
 Bakery products 
 Functional Eggs 
 Spreads 
 Consumer acceptance of FF 
5. Conclusion
Introduction 
 Over the last 20 years the number of “Nutraceuticals” available 
for self-medication in pharmacies or for sale in supermarkets and 
“Health food” shops has grown enormously, fostered by wide 
media coverage of their benefits. 
 There has been a boom in their sales as patients rush to self-medicate, 
either in the hope that these products will be effective 
in treating diseases unsatisfactorily treated with pharmaceuticals, 
or that the adverse effects of some pharmaceuticals may be 
avoided.
Nutraceuticals 
 Dr Stephen De Felice, coined the term ‘Nutraceutical’ and 
defined it as a ‘food, or parts of a food, that provide medical or 
health benefits, including the prevention and treatment of 
disease’. 
 Another definition from the USA is ‘diet supplement that 
delivers a concentrated form of a presumed bioactive agent 
from a food, presented in a non-food matrix, and used to 
enhance health in dosages that exceed those that could be 
obtained from normal food’.
Relationship between 
Nutraceuticals and other health 
products
 Pharmaceuticals are usually classed as medicines by law, 
but some are freely available without legal constraints and 
some are legally classed as medicines. For example, in 
certain countries melatonin is classed as a medicine and is 
not freely available. 
 Herbal remedies may be classed as medicines because of 
their perceived risks with self-medication. 
 Functional foods are closely related to nutraceuticals as 
they often contain nutraceuticals in a food-based formulation, 
such as carotenoids, but others are novel biotechnological 
entities derived from foods, for instance, pre- and probiotics. A 
new term for these has recently been coined – ‘Phoods’ – 
which presumably aims to blur the distinction between 
pharmaceuticals and foods in the minds of consumers. 
 Vitamins can also be classed as medicines, but may be 
freely available. The distinction between certain vitamins and 
nutraceuticals is blurred (e.g. β-carotene, which is a vitamin A
Why consumers choose 
alternative over conventional 
remedies? 
o Many patients are not satisfied with the treatment they are 
given by their doctors due to adverse effects or because it 
has been ineffective. 
o Another reason for choosing alternative over conventional 
remedies is that patients may feel that conventional 
medicine is impersonal or technologically orientated. 
o Some patients prefer to have personal control over their 
healthcare and therefore are happier to self-select than be 
told what to take by their doctor.
NUTRACEUTICAL 
FORMULATIONS AVAILABLE 
• Manufacturers are increasingly 
marketing novel formulations. 
• Tablets, capsules and softgels are 
still the most widely available 
formulations, but new formulations 
such as soft chews, and fast 
dissolving tablets and strips are 
becoming available. 
• As with pharmaceuticals, 
nutraceutical manufacturers are 
extolling the virtues of controlled 
release formulations for release of 
precise levels of active entities over 
a particular time period, in order to 
achieve maximum therapeutic 
effects. An example of the use of 
this technology is the Novasoy soya 
isoflavone range.
S.N NUTRACEUTICAL SOURCE Therapeutic area Formulation Available 
1 Glucosamine Bovine trachea, shellfish Joint, skin and animal health Tablet, capsule, patch, gel, 
effervescent tablet, 
sustained release tablet. 
2 Chondroitin Bovine trachea/cartilage Joint and veterinary health Tablet, nasal drops 
3 Methylsulfonyl-methane 
Meat, milk, capers, etc. Joint and veterinary health Tablet, capsule, cream, 
powder 
4 Coenzyme Q10 Common foods Cardiovascular health, cancer 
prevention, respiratory, skin and 
animal health (antioxidant) 
Tablet, capsule, chewtab, 
drops, gel, gum, softgel 
5 Melatonin Bovine pineal glands Cardiovascular health, cancer 
prevention, sport enhancement, sleep 
improvement & bone health 
(antioxidant) 
Tablet, patch, liquid 
6 Carnitine Heart, skeletal muscle Sport enhancement, cardiovascular 
and bone health, weight optimisation, 
veterinary health 
Tablet 
7 Acetyl-L-carnitine Brain, liver, kidney Mental health, sport enhancement, 
weight management 
Capsule 
8 Octacosanol/ 
policosanol 
Sugarcane waste, 
wheatgerm, rice bran 
Cardiovascular health, sport 
enhancement 
Tablet, capsule 
MAJOR NUTRACEUTICALS
S.N NUTRACEUTICAL SOURCE Therapeutic area Formulation Available 
9 S-Adenosyl methionine Meat, yeast, vegetable26 Joint and mental health Tablet 
10 Docosahexaenoic 
acid/eicosapentaenoic 
acid (DHA/EPA) 
Fish, algae, plankton,29 
seal blubber30 
Joint, cardiovascular, eye and 
mental health, cancer 
prevention, bone, respiratory, 
skin and veterinary health 
Oil, soft capsule 
11 ɣ-Linolenic acid Oenothera biennis, 
Borago officinalis 
Skin health, joint health Oil, soft capsule 
12 α-Linolenic acid Linum usitatissimum Cancer prevention, respiratory 
health (antioxidant) 
Soft capsule 
13 Conjugated linoleic acid Beef, dairy products37 Weight management, sport 
enhancement 
Soft capsule 
14 Flax lignans Linum usitatissimum Cardiovascular health, cancer 
prevention, women’s health 
(antioxidant and weakly 
oestrogenic) 
Soft capsule 
15 Pycnogenol Pinus pinaster Cardiovascular, eye, respiratory, 
and oral health (antioxidant) 
Capsule 
16 Resveratrol Red wine, Polygonum 
capsidatum root, 
Veratrum sp., 
Vaccinium macrocarpon 
Cardiovascular health, cancer 
prevention, women’s health 
(antioxidant & weakly 
oestrogenic) 
Tablet, capsule
S.N NUTRACEUTICAL SOURCE Therapeutic area Formulation Available 
17. Grape seed 
proanthocyanidin extract 
(GSPE) 
Vitis vinifera Cardiovascular and skin health 
(antioxidant) 
Tablet, capsule, patch, gel, 
effervescent tablet, 
sustained release tablet 
18 Lycopene Foods, including 
tomato, green algae 
Cardiovascular and respiratory 
health, cancer prevention 
(antioxidant) 
Tablet, capsule, oral gel 
19 Lutein Tomato, butternut 
squash 
Cardiovascular, eye and skin health 
(antioxidant) 
Capsule 
20 Zeaxanthin Butternut squash Eye health (antioxidant) Capsule 
21 Astaxanthin Fish, shellfish Eye and veterinary health 
(antioxidant) 
Tablet, capsule, liquid 
22 Lipoic acid Meat, liver Cardiovascular and mental health, 
veterinary health 
Tablet 
23 Dehydroepiandrosterone Wild yams Cardiovascular and mental health, 
veterinary health 
Tablet 
24 Soy isoflavones Soy and fermented soy 
products 
Cardiovascular, mental, bone, 
women’s and skin health, cancer 
prevention (antioxidant and 
oestrogenic) 
Tablet, powder 
25 Green tea extracts Camelia sinensis Cardiovascular, bone, skin and oral 
health, cancer prevention and 
weight management (antioxidant) 
Tablet, capsule, powder, 
tea 
26 Creatine Skeletal muscle Mental health, sport enhancement Tablet, capsule, 
effervescent tablet, liquid
Predicted growth rate of nutraceutical 
usage 
Permission to use this data from Dr C Gaertner, Cognis, is gratefully acknowledged.
USE OF NUTRACEUTICALS FOR TREATING SPECIFIC DISEASES 
s.no. Medical condition Incidence of use (%) 
Nutraceuticals used 
1 Prostate cancer 5.3 Lycopene, 
dehydroepiandrosterone 
2 Enlarged prostate 16.9 Lycopene 
3 Osteoarthritis 29.7 Glucosamine, chondroitin, 
methylsulfonylmethane 
4 Neck, back, or joint pain 25.3 Glucosamine, chondroitin, 
methylsulfonylmethane 
5 Degenerative eye 
conditions 
9.9 Lutein 
6 Memory loss 8.9 Fish oil, coenzyme Q10 
7 Insomnia 20.0 Melatonin 
8 Perimenopause 4.6 Soy products 
Data extracted from Gunther S, Patterson R E, Kristal A R, Stratton K L, White E. Demographic and health-related 
correlates of herbal and specialty supplement use, Journal of the American Dietetic Association 2004; 104: 27–34, 
with permission from the American Dietetic Association.
Manufacture and Analysis of major 
Nutraceuticals 
 Most nutraceuticals are natural products, being derived roughly equally 
from plants & animals. Some are endogenous human metabolites, while 
others are common dietary constituents that appear in human metabolism, 
for example lycopene. A number of entities exist in higher plants, and are 
commercially extracted from them, although some are present in 
insufficient levels for commercial exploitation, such as 
methylsulfonylmethane (MSM) and dehydroepiandrosterone (DHEA), and 
consequently are produced commercially by chemical synthesis. 
 Similarly, those of animal origin may be produced by chemical synthesis, 
(e.g.carnitine, creatine and the carotenoids,) but may also be produced by 
fermentation, e.g coenzyme Q10 (Co Q10) and S-adenosyl methionine 
(SAMe). 
 The n-3 fatty acids such as DHA)/EPA and ALA are usually available as complex 
mixtures, containing supradietary levels of the active constituents, and often 
partial purification from the other fatty acids is not carried out..
 In certain cases nutraceuticals exist in a number of isomeric forms, 
which may have varied activities or even be toxic; e.g carnitine, in 
which the D-form is toxic and thus chiral synthesis of the L-form is 
carried out. 
 A number of nutraceuticals have GRAS (Generally Recognized 
As Safe) status as defined by the US Food and Drug 
Administration (FDA), and increasingly manufacturers are gaining 
GRAS certification for products not normally ingested (in realistic 
levels) by consumption of foodstuffs, such as MSM and 
octacosanol/policosanol. 
 As with pharmaceuticals, the analytical procedures used for 
identification and quantification of nutraceuticals are becoming 
increasingly sophisticated, reflecting the analytical advances, and 
the desire by manufacturers to produce detailed information about 
levels of active constituents in the natural materials, formulated 
products & also in biological fluids in an attempt to determine the 
fate of ingested entities.
Use of Nutraceutical supplements: demographic trends 
• 57% of 979 adults agreed that they would like to use supplements more often, 
but were unsure of what to buy. This indicated a need for more information to 
be available. (Mintel Market Research in November 1998) 
• prime target users of supplements - middle-aged females with an above average 
income & above average education. There were also occasional users who used 
supplements at a time of illness or stress, rather like a medicine. These users 
were more varied in age and income and were less likely to take supplements on 
a long-term basis.(Mintel Market Research in March 1999 ) 
• Consumers use nutraceutical supplements for many varied reasons e.g., 
– supplementation of a poor diet, 
– to improve overall health, 
– to delay the onset of age-related diseases, 
– after illness, 
– for stress, 
– recommended by a health professional, 
– in pregnancy and slimming, 
– to improve sports performance and to treat symptoms (colds, coughs, arthritis, etc.).
 One survey from 1988 to 1990, of a cohort of 2152 middle to 
older age adults living in Wisconsin found that the use of 
nutraceutical supplements was more prevalent among 
women, people with more than 12 years of education, those 
with relatively low body mass index, people with active 
lifestyles, and people who had never smoked rather than 
current smokers. 
 Surveys concerning the use of specific nutraceuticals: notably 
creatine, cod liver oil and evening primrose oil. Creatine use 
amongst members of health clubs was found to be more 
likely in men using resistance training, and was associated 
with the consumption of dehydroepiandrosterone (DHEA) and 
other supplements used to increase strength. 
 The primary source of information guiding their use was 
found to be popular magazines, as opposed to qualified
 In most countries there is no legislative definition of the term 
and drawing a border line between conventional and 
functional foods is challenging even for nutrition and food 
experts. 
 A ‘functional food’ is a natural or formulated food that has 
enhanced physiological performance or prevents or treats a 
particular disease. This term was first used in Japan, and by 
1998 it was the only country to legally define ‘Foods for 
specified health use’ (FOSHU). 
 Functional food is a ‘food that has a component incorporated 
into it to give it a specific medical or physiological benefit, 
other than purely nutritional benefit’. 
[Department for Environment, Food and Rural Affairs (Defra), UK] 
Functional Foods
Functional food development
1. Concept testing: The process through which innovation in nutritional science 
occurs develops through intersecting alliances of various stakeholders as depicted 
in Fig. 1. Involved are research, industry, regulatory and consumer sector 
interests. 
2. Product development: develop a real-world test product that embraces that 
concept. For instance, production of a probiotic enriched yogurt, a cheese 
enriched with omega 3 fats. 
3. Efficacy/safety and evidence: Expression of a nutrition health concept through 
development of a product needs to be followed by verification that the product will 
mirror the original concept through the testing of biological efficacy. Efficacy 
assessment is an essential element of establishing the credibility of functional 
food entities , performed using in vitro or in vivo systems. Evidence also needs to 
be provided by parallel studies conducted across several jurisdictions and 
conducted in both academic and private sector institutional laboratories. 
4. Publication: for dissemination of biological efficacy data is through publications 
in peer-reviewed journals. It is equally important that negative, as well as positive, 
efficacy and safety results be disseminated through peer-reviewed publication in 
order to provide a balanced evaluation of the true merits of that ingredient.
5.Health claims and regulatory review: involves 
communication of the health messages generated through 
active research and regulatory review of a specific food 
product to the general public. Regulatory review is required in 
order to translate peer-reviewed published data supporting the 
efficacy and safety of a given bioactive product within a novel 
food matrix or capsule into policy changes consistent with 
approving products for sale of functional food products. 
 In the UK, the Joint Health Claims Initiative (JHCI) provides guidance on 
claims that are allowed for functional foods, such as fortified breakfast 
cereals and ‘bio’-yoghurts. In some cases although medical claims such 
as ‘helps prevent heart disease’ are not allowed, health promoting claims, 
such as ‘helps lower cholesterol’ can be made, if scientific evidence 
exists. 
 Companies marketing nutraceuticals cannot advertise specific medical 
claims for their products without a medicine licence. When launching a 
new product they have the option of either not doing any research at all 
or researching it thoroughly and possibly obtaining a patent.
 Unfortunately many companies tend towards the 
former route because of the expense, To bring a 
medicine to market can take about ten years and cost 
US$0.8–1.7 billion,9 but to market an unlicensed 
nutraceutical can take a fraction of this time and 
money. 
6.Industry growth Securing specific messages on 
foods attesting to their health benefits represents a vital 
part of the cycle of moving a functional food from 
concept to a marketing success story. Given that 
consumers are both interested and informed about foods 
that confer health benefits beyond simply providing 
nutrients (Heller, 2006) the presence of an informative, 
authoritative claim on a food will stimulate the market 
share penetration of that product within its sector.
Functional food products 
 Most early developments of functional foods were those of fortified 
with vitamins and/or minerals such as vitamin C, vitamin E, folic acid, 
zinc, iron, and calcium. 
 Subsequently, the focus shifted to foods fortified with various 
micronutrients such as omega-3 fatty acid, phytosterol, and soluble 
fiber to promote good health or to prevent diseases such as cancers. 
 More recently, food companies have taken further steps to develop 
food products that offer multiple health benefits in a single food. 
 Functional food products are not homogeneously scattered over all 
segments of the food and drink market and consumer health 
concerns and product preferences may vary between markets. These 
products have been mainly launched in the dairy-, confectionery-, 
soft-drinks-, bakery- and baby-food market (Kotilainen et al., 2006; 
Menrad, 2003).
Probiotics 
 Probiotics are defined as ‘‘live microorganisms, as they are consumed in adequate numbers 
confer a health benefit on the host’’. 
 Lactic acid bacteria (LAB) and bifidobacteria, the most studied and widely employed bacteria 
within the probiotic field. 
 Dairy products are the key product sector. The sensitivity of probiotics to physical and chemical 
stress, heat and acidity makes the product development challenging for other type of food 
product. Recently encapsulation was assessed as possible technology for decreasing sensitivity 
of such probiotics (Clair, 2007; Mattila-Sandholm et al, 2002). 
 Extensive R&D activity resulted in a number of special new dairy products (e.g. Synbiofir 
drinking kefir, Synbioghurt drinking yoghurt, HunCult fermented drink, Milli Premium sour 
cream, Aktivit quark dessert, New Party butter cream, Probios cheese cream) (Szaka´ ly, 2007). 
 Fruit juice has also been suggested as a novel, appropriate medium for fortification with 
probiotic cultures because it is already positioned as a healthy food product, and it is consumed 
frequently and loyally by a large % of the consumer population (Tuorila & Cardello, 2002).
 Prebiotics are non-digestible food ingredients that beneficially affect the host by 
stimulating the growth and/or activity of one or a limited number of bacteria in the colon, 
thus improving host health. (Charalampopoulos et al., 2003; Stanton et al., 2005) 
 Fructo-oligosaccharide (FOS), inulin, isomalto-oligosaccharides (IMO), polydextrose, 
lactulose and resistant starch are considered as the main prebiotic components. 
 Primarily oligosaccharides, such as soy oligosaccharides (SOS), galacto-oligosaccharides 
(GOS) and xylo-oligosaccharides (XOS) are also marketed in Japan (Ouwehand, 2007). 
 Oligosaccharides play important role in obesity control through resulting increased satiety 
and reduced hunger (Bosscher, 2007; Bosscher, Van Loo, & Franck, 2006; Cani, 
Neyrinck, Maton, & Delzenne, 2005). 
 Inulin and oligofructose besides being prebiotics, have shown to increase calcium 
absorption, thus improve both bone mineral content and bone mineral density (BMD) 
(Bosscher et al, 2006). Furthermore, they influence the formation of blood glucose, and 
reduce the levels of cholesterol and serum lipids (Lo´ pez-Molina et al., 2005). 
 SYNBIOTICS: foods containing a combination of probiotics and prebiotics .
 Consists of non-alcoholic beverages fortified with vitamins A, C and E 
or other functional ingredients. 
 Although, there is a relatively high number of a product available in this 
segment, the market is still small and fragmented. 
 Other types of functional drinks are those of cholesterol lowering drinks 
(with combination of omega-3 and soy), ‘‘eye health’’ drinks (with lutein) 
or ‘‘bone health’’ drinks (with calcium and inulin) (Keller, 2006). 
 In Estonia, for example fortified juices are produced under the trade 
name of Largo containing inulin, L-carnitine, vitamins, Ca and Mg as 
functional ingredients.
 Cereals, in particular oat and barley. 
 The multiple beneficial effects of cereals can be exploited in different 
ways leading to the design of novel cereal foods or cereal ingredients 
that can target specific populations. 
 Cereals can be used as 
 fermentable substrates for the growth of probiotic microorganisms 
 as sources of non-digestible carbohydrates that besides promoting several 
beneficial physiological effects can act as prebiotics. 
 cereal constituents, such as starch, can be used as encapsulation materials for 
probiotics in order to improve their stability during storage and enhance their 
viability during their passage through the adverse conditions of the 
gastrointestinal tract (Brennan & Cleary, 2005; Charalampopoulos et al., 2002). 
 functional cereal components e.g., beta-glucan, are also applied in the dairy 
and bakery industries for the manufacture of low-fat ice creams and yogurts. It 
makes their mouthfeel, scoopability and sensory properties resemble those of 
full-fat products (Brennan & Cleary, 2005).
 In relation to Functional foods bakery is still relatively underdeveloped. 
Bakery products however provide ideal matrix by which functionality can 
be delivered to the consumer in an acceptable food. 
 It is important to realize that achieving functional food quality does not 
simply involve delivering the active principle at the appropriate level for 
physiological effectiveness, but also supplying a product which meets 
the consumer’s requirements in terms of appearance, taste and texture 
(Alldrick, 2007). 
 In late 2003, Unilever innovated the bakery sector 
by introducing a white bread called Blue Band 
Goede Start, which was the first white bread 
containing the nutritional elements normally 
available in brown bread including fibers, vitamins 
B1, B3 and B6; iron; zinc; inulin, a starch that 
comes from wheat (Benkouider, 2005a).
 It can be assumed that cholesterol-lowering spreads will gain increasing 
relevance in the coming years due to the market introduction of e.g. a 
functional variety of Becel1 margarine of Unilever (named ‘‘Becel pro-activ’’), 
containing phytostanol esters which are supposed to lower the 
cholesterol level. 
 Low-cholesterol butter under the trade name of BaladeTM has been 
produced and marketed in Belgium since 1992. In this case more than 
90% of the cholesterol in milk fat has been removed by the addition of 
crystalline betacyclodextrin to the molten butter. 
 Other low-cholesterol milk products, like cheese, cream, or even low-cholesterol 
egg, are produced by this technology .
Functional eggs 
 Eggs are of particular interest from a functionality point of view, because 
they are relatively rich in fatty acids and the associated fat-soluble 
compounds. 
 The idea of egg enrichment with omega-3 FAs simultaneously with 
antioxidants & other vitamins has recently been used to produce VITA 
eggs by Freshlay Foods (Devon, UK). They state that their eggs were 
enriched with omega-3 fatty acids, Se, vitamins D, E, B12 and folic acid. 
 Eggs enriched in omega-3 and vitamin E produced by Belovo under the 
trade name of Columbus first appeared in Belgium in 1997, and since 
then they have been sold in the UK (from 1998), The Netherlands (from 
1999), India, Japan and South Africa (from 2000). Currently, production 
of Columbus egg exceeds 50 millions/year in Europe. 
 Similar eggs are produced by Pilgrim’s Pride Company, Gold Circle Farms 
and OmegaTech in the USA (Surai & Sparks, 2001).
CONSUMER ACCEPTANCE 
OF FUNCTIONAL FOODS 
 socio-demographic characteristics, cognitive and attitudinal factors emerged as potential 
determinants 
 studies showed that consumer acceptance of functional foods is far from being 
unconditional, with one of the main conditions for acceptance pertaining to taste, besides 
trustworthiness of health claims. Although increasing the functionality of the food should 
not necessarily change its sensory quality (Urala & La¨hteenma¨ ki, 2004), bitter, acrid, 
astringent or salty off-flavours often inherently result from enhancing food functionality 
with bioactive compounds or plant-based phytonutrients. 
 most of these studies identified typical functional food consumer as being female, well 
educated, higher income class and older than 55. 
 Given the fact that prevention is a major motivation of use of functional food (Verbeke, 
2006; Wrick, 1995), it can logically be hypothesized that experience with illnesses increases 
probabilities of functional food acceptance 
 Relatively high price can be regarded as one reason for the limited market success of 
several functional food products.
Conclusion 
• Nutraceuticals & functional foods generate one of the most promising and 
dynamically developing segments of food industry. 
• Increasing consumer awareness in combination with new advances in various 
scientific domains is supporting the inflow of functional product. 
• In the case of a successful product development attention should be paid both to 
consumer demands and technical conditions, furthermore, the legislation background 
should not be neglected. Consumer acceptance is key success factor. 
• Consumer Acceptance, is determined by factors like primary health concerns, 
consumers’ familiarity with the ‘‘functional food’’ concepts and with the functional 
ingredients, the nature of the carrier product, the manner of health effect 
communication, etc. 
• Main conditions for acceptance of functional foods is pertaining to taste, besides, 
product quality, price, convenience and trustworthiness of health claims. 
• By purchasing functional foods in general consumers may achieve a modern and 
positive impression of themselves. These products provide consumers a modern way 
to follow a healthy lifestyle, which differs from the conventionally healthy diet defined 
by nutrition experts.
Development of Nutraceuticals & functional foods

More Related Content

PPTX
Nutraceuticals and functional foods
PPTX
Functional food
PPSX
Nutraceuticals
PDF
Functional Foods: Their Role & Opportunities
PDF
Giáo trình Phương pháp nghiên cứu khoa học - Khoa Y Dược (ĐHQGHN).pdf
PPTX
Production of cheese
PPTX
Industrial production of important amino acids
PPTX
Nutraceuticals
Nutraceuticals and functional foods
Functional food
Nutraceuticals
Functional Foods: Their Role & Opportunities
Giáo trình Phương pháp nghiên cứu khoa học - Khoa Y Dược (ĐHQGHN).pdf
Production of cheese
Industrial production of important amino acids
Nutraceuticals

What's hot (20)

PPTX
PPTX
Functional foods
PPTX
Functional Foods and Nutraceuticals
DOCX
nutraceuticals and functional food
PPTX
Medical foods
PPTX
Nutraceutical and diseases
PPTX
3. Classification of nutraceuticals.pptx
PPTX
Functional foods & Nutraceuticals
PPTX
Nutraceuticals
PPT
Health benefits of functional food
PPTX
PPTX
Nutraceuticals
PPTX
Adverse effects and toxicity of nutraceuticals
PPTX
Roles of nutraceuticals
PPTX
Nutraceutical
PPTX
Functional foods
PPTX
Flavour in food industries
PPTX
Cereal products as functional foods
Functional foods
Functional Foods and Nutraceuticals
nutraceuticals and functional food
Medical foods
Nutraceutical and diseases
3. Classification of nutraceuticals.pptx
Functional foods & Nutraceuticals
Nutraceuticals
Health benefits of functional food
Nutraceuticals
Adverse effects and toxicity of nutraceuticals
Roles of nutraceuticals
Nutraceutical
Functional foods
Flavour in food industries
Cereal products as functional foods
Ad

Viewers also liked (14)

PDF
Personalised Medicine In R & D
PPTX
NUTRACEUTICALS : LET FOOD BE UR MEDICINE
PPTX
Role of emergency endoscopy in saving lives dr ravi gupta
PPT
Nutraceuticals by Priyanka Khokhar
PDF
Introduction to pharmacovigilance
PPT
FUTURE OF LAPAROSCOPY
PPTX
Basics Of Pharmacovigilance
PPTX
Pharmacovigilance
PPTX
Pharmacotherapy
PPT
Pharmacovigilance full information
PPTX
THERAPEUTIC ENDOSCOPY IN GI SURGERY
PPTX
Endoscopy
PPTX
Endoscopy
PDF
Upper GI Endoscopy - A pictorial overview
Personalised Medicine In R & D
NUTRACEUTICALS : LET FOOD BE UR MEDICINE
Role of emergency endoscopy in saving lives dr ravi gupta
Nutraceuticals by Priyanka Khokhar
Introduction to pharmacovigilance
FUTURE OF LAPAROSCOPY
Basics Of Pharmacovigilance
Pharmacovigilance
Pharmacotherapy
Pharmacovigilance full information
THERAPEUTIC ENDOSCOPY IN GI SURGERY
Endoscopy
Endoscopy
Upper GI Endoscopy - A pictorial overview
Ad

Similar to Development of Nutraceuticals & functional foods (20)

PPTX
Unit Nutraceuticals classification and Health Benefits (4).pptx
PPT
Nutraceutical
PPTX
Nutraceuticals
PPT
nutracuticals
PPTX
Neutraceuticals;functional foods
PDF
13 nutraceuticles
PDF
nutraceutical.pdf, PHARMACOGNOSY, DIPLOMA 1 YR
PDF
nutraceuticals-240315090614-ad5cf274.pdf
PPTX
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...
PPTX
Recent Advancements In Formulation Approaches And Regulatory Aspect Of Nutrac...
PPTX
Nutraceuticals & functional foods
PDF
Nutraceuticals ppt.pdf by Nitisha Tandon
PPTX
Nutraceuticals
PDF
Let nutra be your medicine rev.
PPTX
NUTRACEUTICALS
PPTX
Classification of Nutraceuticals.pptx
PDF
A review on nutraceuticals
DOCX
Assignment of analytical chemistry(neutraceuticals)
PPTX
General aspects of nutraceuticals
Unit Nutraceuticals classification and Health Benefits (4).pptx
Nutraceutical
Nutraceuticals
nutracuticals
Neutraceuticals;functional foods
13 nutraceuticles
nutraceutical.pdf, PHARMACOGNOSY, DIPLOMA 1 YR
nutraceuticals-240315090614-ad5cf274.pdf
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...
Recent Advancements In Formulation Approaches And Regulatory Aspect Of Nutrac...
Nutraceuticals & functional foods
Nutraceuticals ppt.pdf by Nitisha Tandon
Nutraceuticals
Let nutra be your medicine rev.
NUTRACEUTICALS
Classification of Nutraceuticals.pptx
A review on nutraceuticals
Assignment of analytical chemistry(neutraceuticals)
General aspects of nutraceuticals

More from Ekta Belwal (7)

PPTX
Weight loss diets
PPTX
Milk and milk products
PPTX
factors affecting Decision making
PPT
Nutrition for Women health
PPTX
Nutritional Anthropometry
PPTX
Role of mass media
PPTX
Preparing, Diluting of solutions of different Strengths & safety measures whi...
Weight loss diets
Milk and milk products
factors affecting Decision making
Nutrition for Women health
Nutritional Anthropometry
Role of mass media
Preparing, Diluting of solutions of different Strengths & safety measures whi...

Recently uploaded (20)

PDF
DAY-6. Summer class. Ppt. Cultural Nursing
PDF
CHAPTER 9 MEETING SAFETY NEEDS FOR OLDER ADULTS.pdf
PPTX
Pulmonary Circulation PPT final for easy
PDF
MINERAL & VITAMIN CHARTS fggfdtujhfd.pdf
PDF
NUTRITION THROUGHOUT THE LIFE CYCLE CHILDHOOD -AGEING
PPTX
Rheumatic heart diseases with Type 2 Diabetes Mellitus
PDF
A Brief Introduction About Malke Heiman
PDF
Structure Composition and Mechanical Properties of Australian O.pdf
PPT
Parental-Carer-mental-illness-and-Potential-impact-on-Dependant-Children.ppt
PDF
Khaled Sary- Trailblazers of Transformation Middle East's 5 Most Inspiring Le...
PPTX
COMMUNICATION SKILSS IN NURSING PRACTICE
PPTX
PEDIATRIC OSCE, MBBS, by Dr. Sangit Chhantyal(IOM)..pptx
PDF
MECE & SCQA FRAMEWORKS, - Adding Innovation & Influencing Hospital & Super-Sp...
PPT
Adrenergic drugs (sympathomimetics ).ppt
PPT
Microscope is an instrument that makes an enlarged image of a small object, t...
PPT
KULIAH UG WANITA Prof Endang 121110 (1).ppt
PPTX
CBT FOR OCD TREATMENT WITHOUT MEDICATION
PPTX
NUTRITIONAL PROBLEMS, CHANGES NEEDED TO PREVENT MALNUTRITION
PPTX
Medical aspects of impairment including all the domains mentioned in ICF
PPTX
1. Drug Distribution System.pptt b pharmacy
DAY-6. Summer class. Ppt. Cultural Nursing
CHAPTER 9 MEETING SAFETY NEEDS FOR OLDER ADULTS.pdf
Pulmonary Circulation PPT final for easy
MINERAL & VITAMIN CHARTS fggfdtujhfd.pdf
NUTRITION THROUGHOUT THE LIFE CYCLE CHILDHOOD -AGEING
Rheumatic heart diseases with Type 2 Diabetes Mellitus
A Brief Introduction About Malke Heiman
Structure Composition and Mechanical Properties of Australian O.pdf
Parental-Carer-mental-illness-and-Potential-impact-on-Dependant-Children.ppt
Khaled Sary- Trailblazers of Transformation Middle East's 5 Most Inspiring Le...
COMMUNICATION SKILSS IN NURSING PRACTICE
PEDIATRIC OSCE, MBBS, by Dr. Sangit Chhantyal(IOM)..pptx
MECE & SCQA FRAMEWORKS, - Adding Innovation & Influencing Hospital & Super-Sp...
Adrenergic drugs (sympathomimetics ).ppt
Microscope is an instrument that makes an enlarged image of a small object, t...
KULIAH UG WANITA Prof Endang 121110 (1).ppt
CBT FOR OCD TREATMENT WITHOUT MEDICATION
NUTRITIONAL PROBLEMS, CHANGES NEEDED TO PREVENT MALNUTRITION
Medical aspects of impairment including all the domains mentioned in ICF
1. Drug Distribution System.pptt b pharmacy

Development of Nutraceuticals & functional foods

  • 2. Contents 1. Introduction 2. Relationship between Nutraceuticals and other health products 3. Nutraceuticals  Major Nutraceuticals: manufacture, source and use  Demographic trends for use of Nutraceutical supplements 4. Functional Foods  FF development  Probiotics  Prebiotics  Functional drinks  Functional cereals  Bakery products  Functional Eggs  Spreads  Consumer acceptance of FF 5. Conclusion
  • 3. Introduction  Over the last 20 years the number of “Nutraceuticals” available for self-medication in pharmacies or for sale in supermarkets and “Health food” shops has grown enormously, fostered by wide media coverage of their benefits.  There has been a boom in their sales as patients rush to self-medicate, either in the hope that these products will be effective in treating diseases unsatisfactorily treated with pharmaceuticals, or that the adverse effects of some pharmaceuticals may be avoided.
  • 4. Nutraceuticals  Dr Stephen De Felice, coined the term ‘Nutraceutical’ and defined it as a ‘food, or parts of a food, that provide medical or health benefits, including the prevention and treatment of disease’.  Another definition from the USA is ‘diet supplement that delivers a concentrated form of a presumed bioactive agent from a food, presented in a non-food matrix, and used to enhance health in dosages that exceed those that could be obtained from normal food’.
  • 5. Relationship between Nutraceuticals and other health products
  • 6.  Pharmaceuticals are usually classed as medicines by law, but some are freely available without legal constraints and some are legally classed as medicines. For example, in certain countries melatonin is classed as a medicine and is not freely available.  Herbal remedies may be classed as medicines because of their perceived risks with self-medication.  Functional foods are closely related to nutraceuticals as they often contain nutraceuticals in a food-based formulation, such as carotenoids, but others are novel biotechnological entities derived from foods, for instance, pre- and probiotics. A new term for these has recently been coined – ‘Phoods’ – which presumably aims to blur the distinction between pharmaceuticals and foods in the minds of consumers.  Vitamins can also be classed as medicines, but may be freely available. The distinction between certain vitamins and nutraceuticals is blurred (e.g. β-carotene, which is a vitamin A
  • 7. Why consumers choose alternative over conventional remedies? o Many patients are not satisfied with the treatment they are given by their doctors due to adverse effects or because it has been ineffective. o Another reason for choosing alternative over conventional remedies is that patients may feel that conventional medicine is impersonal or technologically orientated. o Some patients prefer to have personal control over their healthcare and therefore are happier to self-select than be told what to take by their doctor.
  • 8. NUTRACEUTICAL FORMULATIONS AVAILABLE • Manufacturers are increasingly marketing novel formulations. • Tablets, capsules and softgels are still the most widely available formulations, but new formulations such as soft chews, and fast dissolving tablets and strips are becoming available. • As with pharmaceuticals, nutraceutical manufacturers are extolling the virtues of controlled release formulations for release of precise levels of active entities over a particular time period, in order to achieve maximum therapeutic effects. An example of the use of this technology is the Novasoy soya isoflavone range.
  • 9. S.N NUTRACEUTICAL SOURCE Therapeutic area Formulation Available 1 Glucosamine Bovine trachea, shellfish Joint, skin and animal health Tablet, capsule, patch, gel, effervescent tablet, sustained release tablet. 2 Chondroitin Bovine trachea/cartilage Joint and veterinary health Tablet, nasal drops 3 Methylsulfonyl-methane Meat, milk, capers, etc. Joint and veterinary health Tablet, capsule, cream, powder 4 Coenzyme Q10 Common foods Cardiovascular health, cancer prevention, respiratory, skin and animal health (antioxidant) Tablet, capsule, chewtab, drops, gel, gum, softgel 5 Melatonin Bovine pineal glands Cardiovascular health, cancer prevention, sport enhancement, sleep improvement & bone health (antioxidant) Tablet, patch, liquid 6 Carnitine Heart, skeletal muscle Sport enhancement, cardiovascular and bone health, weight optimisation, veterinary health Tablet 7 Acetyl-L-carnitine Brain, liver, kidney Mental health, sport enhancement, weight management Capsule 8 Octacosanol/ policosanol Sugarcane waste, wheatgerm, rice bran Cardiovascular health, sport enhancement Tablet, capsule MAJOR NUTRACEUTICALS
  • 10. S.N NUTRACEUTICAL SOURCE Therapeutic area Formulation Available 9 S-Adenosyl methionine Meat, yeast, vegetable26 Joint and mental health Tablet 10 Docosahexaenoic acid/eicosapentaenoic acid (DHA/EPA) Fish, algae, plankton,29 seal blubber30 Joint, cardiovascular, eye and mental health, cancer prevention, bone, respiratory, skin and veterinary health Oil, soft capsule 11 ɣ-Linolenic acid Oenothera biennis, Borago officinalis Skin health, joint health Oil, soft capsule 12 α-Linolenic acid Linum usitatissimum Cancer prevention, respiratory health (antioxidant) Soft capsule 13 Conjugated linoleic acid Beef, dairy products37 Weight management, sport enhancement Soft capsule 14 Flax lignans Linum usitatissimum Cardiovascular health, cancer prevention, women’s health (antioxidant and weakly oestrogenic) Soft capsule 15 Pycnogenol Pinus pinaster Cardiovascular, eye, respiratory, and oral health (antioxidant) Capsule 16 Resveratrol Red wine, Polygonum capsidatum root, Veratrum sp., Vaccinium macrocarpon Cardiovascular health, cancer prevention, women’s health (antioxidant & weakly oestrogenic) Tablet, capsule
  • 11. S.N NUTRACEUTICAL SOURCE Therapeutic area Formulation Available 17. Grape seed proanthocyanidin extract (GSPE) Vitis vinifera Cardiovascular and skin health (antioxidant) Tablet, capsule, patch, gel, effervescent tablet, sustained release tablet 18 Lycopene Foods, including tomato, green algae Cardiovascular and respiratory health, cancer prevention (antioxidant) Tablet, capsule, oral gel 19 Lutein Tomato, butternut squash Cardiovascular, eye and skin health (antioxidant) Capsule 20 Zeaxanthin Butternut squash Eye health (antioxidant) Capsule 21 Astaxanthin Fish, shellfish Eye and veterinary health (antioxidant) Tablet, capsule, liquid 22 Lipoic acid Meat, liver Cardiovascular and mental health, veterinary health Tablet 23 Dehydroepiandrosterone Wild yams Cardiovascular and mental health, veterinary health Tablet 24 Soy isoflavones Soy and fermented soy products Cardiovascular, mental, bone, women’s and skin health, cancer prevention (antioxidant and oestrogenic) Tablet, powder 25 Green tea extracts Camelia sinensis Cardiovascular, bone, skin and oral health, cancer prevention and weight management (antioxidant) Tablet, capsule, powder, tea 26 Creatine Skeletal muscle Mental health, sport enhancement Tablet, capsule, effervescent tablet, liquid
  • 12. Predicted growth rate of nutraceutical usage Permission to use this data from Dr C Gaertner, Cognis, is gratefully acknowledged.
  • 13. USE OF NUTRACEUTICALS FOR TREATING SPECIFIC DISEASES s.no. Medical condition Incidence of use (%) Nutraceuticals used 1 Prostate cancer 5.3 Lycopene, dehydroepiandrosterone 2 Enlarged prostate 16.9 Lycopene 3 Osteoarthritis 29.7 Glucosamine, chondroitin, methylsulfonylmethane 4 Neck, back, or joint pain 25.3 Glucosamine, chondroitin, methylsulfonylmethane 5 Degenerative eye conditions 9.9 Lutein 6 Memory loss 8.9 Fish oil, coenzyme Q10 7 Insomnia 20.0 Melatonin 8 Perimenopause 4.6 Soy products Data extracted from Gunther S, Patterson R E, Kristal A R, Stratton K L, White E. Demographic and health-related correlates of herbal and specialty supplement use, Journal of the American Dietetic Association 2004; 104: 27–34, with permission from the American Dietetic Association.
  • 14. Manufacture and Analysis of major Nutraceuticals  Most nutraceuticals are natural products, being derived roughly equally from plants & animals. Some are endogenous human metabolites, while others are common dietary constituents that appear in human metabolism, for example lycopene. A number of entities exist in higher plants, and are commercially extracted from them, although some are present in insufficient levels for commercial exploitation, such as methylsulfonylmethane (MSM) and dehydroepiandrosterone (DHEA), and consequently are produced commercially by chemical synthesis.  Similarly, those of animal origin may be produced by chemical synthesis, (e.g.carnitine, creatine and the carotenoids,) but may also be produced by fermentation, e.g coenzyme Q10 (Co Q10) and S-adenosyl methionine (SAMe).  The n-3 fatty acids such as DHA)/EPA and ALA are usually available as complex mixtures, containing supradietary levels of the active constituents, and often partial purification from the other fatty acids is not carried out..
  • 15.  In certain cases nutraceuticals exist in a number of isomeric forms, which may have varied activities or even be toxic; e.g carnitine, in which the D-form is toxic and thus chiral synthesis of the L-form is carried out.  A number of nutraceuticals have GRAS (Generally Recognized As Safe) status as defined by the US Food and Drug Administration (FDA), and increasingly manufacturers are gaining GRAS certification for products not normally ingested (in realistic levels) by consumption of foodstuffs, such as MSM and octacosanol/policosanol.  As with pharmaceuticals, the analytical procedures used for identification and quantification of nutraceuticals are becoming increasingly sophisticated, reflecting the analytical advances, and the desire by manufacturers to produce detailed information about levels of active constituents in the natural materials, formulated products & also in biological fluids in an attempt to determine the fate of ingested entities.
  • 16. Use of Nutraceutical supplements: demographic trends • 57% of 979 adults agreed that they would like to use supplements more often, but were unsure of what to buy. This indicated a need for more information to be available. (Mintel Market Research in November 1998) • prime target users of supplements - middle-aged females with an above average income & above average education. There were also occasional users who used supplements at a time of illness or stress, rather like a medicine. These users were more varied in age and income and were less likely to take supplements on a long-term basis.(Mintel Market Research in March 1999 ) • Consumers use nutraceutical supplements for many varied reasons e.g., – supplementation of a poor diet, – to improve overall health, – to delay the onset of age-related diseases, – after illness, – for stress, – recommended by a health professional, – in pregnancy and slimming, – to improve sports performance and to treat symptoms (colds, coughs, arthritis, etc.).
  • 17.  One survey from 1988 to 1990, of a cohort of 2152 middle to older age adults living in Wisconsin found that the use of nutraceutical supplements was more prevalent among women, people with more than 12 years of education, those with relatively low body mass index, people with active lifestyles, and people who had never smoked rather than current smokers.  Surveys concerning the use of specific nutraceuticals: notably creatine, cod liver oil and evening primrose oil. Creatine use amongst members of health clubs was found to be more likely in men using resistance training, and was associated with the consumption of dehydroepiandrosterone (DHEA) and other supplements used to increase strength.  The primary source of information guiding their use was found to be popular magazines, as opposed to qualified
  • 18.  In most countries there is no legislative definition of the term and drawing a border line between conventional and functional foods is challenging even for nutrition and food experts.  A ‘functional food’ is a natural or formulated food that has enhanced physiological performance or prevents or treats a particular disease. This term was first used in Japan, and by 1998 it was the only country to legally define ‘Foods for specified health use’ (FOSHU).  Functional food is a ‘food that has a component incorporated into it to give it a specific medical or physiological benefit, other than purely nutritional benefit’. [Department for Environment, Food and Rural Affairs (Defra), UK] Functional Foods
  • 20. 1. Concept testing: The process through which innovation in nutritional science occurs develops through intersecting alliances of various stakeholders as depicted in Fig. 1. Involved are research, industry, regulatory and consumer sector interests. 2. Product development: develop a real-world test product that embraces that concept. For instance, production of a probiotic enriched yogurt, a cheese enriched with omega 3 fats. 3. Efficacy/safety and evidence: Expression of a nutrition health concept through development of a product needs to be followed by verification that the product will mirror the original concept through the testing of biological efficacy. Efficacy assessment is an essential element of establishing the credibility of functional food entities , performed using in vitro or in vivo systems. Evidence also needs to be provided by parallel studies conducted across several jurisdictions and conducted in both academic and private sector institutional laboratories. 4. Publication: for dissemination of biological efficacy data is through publications in peer-reviewed journals. It is equally important that negative, as well as positive, efficacy and safety results be disseminated through peer-reviewed publication in order to provide a balanced evaluation of the true merits of that ingredient.
  • 21. 5.Health claims and regulatory review: involves communication of the health messages generated through active research and regulatory review of a specific food product to the general public. Regulatory review is required in order to translate peer-reviewed published data supporting the efficacy and safety of a given bioactive product within a novel food matrix or capsule into policy changes consistent with approving products for sale of functional food products.  In the UK, the Joint Health Claims Initiative (JHCI) provides guidance on claims that are allowed for functional foods, such as fortified breakfast cereals and ‘bio’-yoghurts. In some cases although medical claims such as ‘helps prevent heart disease’ are not allowed, health promoting claims, such as ‘helps lower cholesterol’ can be made, if scientific evidence exists.  Companies marketing nutraceuticals cannot advertise specific medical claims for their products without a medicine licence. When launching a new product they have the option of either not doing any research at all or researching it thoroughly and possibly obtaining a patent.
  • 22.  Unfortunately many companies tend towards the former route because of the expense, To bring a medicine to market can take about ten years and cost US$0.8–1.7 billion,9 but to market an unlicensed nutraceutical can take a fraction of this time and money. 6.Industry growth Securing specific messages on foods attesting to their health benefits represents a vital part of the cycle of moving a functional food from concept to a marketing success story. Given that consumers are both interested and informed about foods that confer health benefits beyond simply providing nutrients (Heller, 2006) the presence of an informative, authoritative claim on a food will stimulate the market share penetration of that product within its sector.
  • 23. Functional food products  Most early developments of functional foods were those of fortified with vitamins and/or minerals such as vitamin C, vitamin E, folic acid, zinc, iron, and calcium.  Subsequently, the focus shifted to foods fortified with various micronutrients such as omega-3 fatty acid, phytosterol, and soluble fiber to promote good health or to prevent diseases such as cancers.  More recently, food companies have taken further steps to develop food products that offer multiple health benefits in a single food.  Functional food products are not homogeneously scattered over all segments of the food and drink market and consumer health concerns and product preferences may vary between markets. These products have been mainly launched in the dairy-, confectionery-, soft-drinks-, bakery- and baby-food market (Kotilainen et al., 2006; Menrad, 2003).
  • 24. Probiotics  Probiotics are defined as ‘‘live microorganisms, as they are consumed in adequate numbers confer a health benefit on the host’’.  Lactic acid bacteria (LAB) and bifidobacteria, the most studied and widely employed bacteria within the probiotic field.  Dairy products are the key product sector. The sensitivity of probiotics to physical and chemical stress, heat and acidity makes the product development challenging for other type of food product. Recently encapsulation was assessed as possible technology for decreasing sensitivity of such probiotics (Clair, 2007; Mattila-Sandholm et al, 2002).  Extensive R&D activity resulted in a number of special new dairy products (e.g. Synbiofir drinking kefir, Synbioghurt drinking yoghurt, HunCult fermented drink, Milli Premium sour cream, Aktivit quark dessert, New Party butter cream, Probios cheese cream) (Szaka´ ly, 2007).  Fruit juice has also been suggested as a novel, appropriate medium for fortification with probiotic cultures because it is already positioned as a healthy food product, and it is consumed frequently and loyally by a large % of the consumer population (Tuorila & Cardello, 2002).
  • 25.  Prebiotics are non-digestible food ingredients that beneficially affect the host by stimulating the growth and/or activity of one or a limited number of bacteria in the colon, thus improving host health. (Charalampopoulos et al., 2003; Stanton et al., 2005)  Fructo-oligosaccharide (FOS), inulin, isomalto-oligosaccharides (IMO), polydextrose, lactulose and resistant starch are considered as the main prebiotic components.  Primarily oligosaccharides, such as soy oligosaccharides (SOS), galacto-oligosaccharides (GOS) and xylo-oligosaccharides (XOS) are also marketed in Japan (Ouwehand, 2007).  Oligosaccharides play important role in obesity control through resulting increased satiety and reduced hunger (Bosscher, 2007; Bosscher, Van Loo, & Franck, 2006; Cani, Neyrinck, Maton, & Delzenne, 2005).  Inulin and oligofructose besides being prebiotics, have shown to increase calcium absorption, thus improve both bone mineral content and bone mineral density (BMD) (Bosscher et al, 2006). Furthermore, they influence the formation of blood glucose, and reduce the levels of cholesterol and serum lipids (Lo´ pez-Molina et al., 2005).  SYNBIOTICS: foods containing a combination of probiotics and prebiotics .
  • 26.  Consists of non-alcoholic beverages fortified with vitamins A, C and E or other functional ingredients.  Although, there is a relatively high number of a product available in this segment, the market is still small and fragmented.  Other types of functional drinks are those of cholesterol lowering drinks (with combination of omega-3 and soy), ‘‘eye health’’ drinks (with lutein) or ‘‘bone health’’ drinks (with calcium and inulin) (Keller, 2006).  In Estonia, for example fortified juices are produced under the trade name of Largo containing inulin, L-carnitine, vitamins, Ca and Mg as functional ingredients.
  • 27.  Cereals, in particular oat and barley.  The multiple beneficial effects of cereals can be exploited in different ways leading to the design of novel cereal foods or cereal ingredients that can target specific populations.  Cereals can be used as  fermentable substrates for the growth of probiotic microorganisms  as sources of non-digestible carbohydrates that besides promoting several beneficial physiological effects can act as prebiotics.  cereal constituents, such as starch, can be used as encapsulation materials for probiotics in order to improve their stability during storage and enhance their viability during their passage through the adverse conditions of the gastrointestinal tract (Brennan & Cleary, 2005; Charalampopoulos et al., 2002).  functional cereal components e.g., beta-glucan, are also applied in the dairy and bakery industries for the manufacture of low-fat ice creams and yogurts. It makes their mouthfeel, scoopability and sensory properties resemble those of full-fat products (Brennan & Cleary, 2005).
  • 28.  In relation to Functional foods bakery is still relatively underdeveloped. Bakery products however provide ideal matrix by which functionality can be delivered to the consumer in an acceptable food.  It is important to realize that achieving functional food quality does not simply involve delivering the active principle at the appropriate level for physiological effectiveness, but also supplying a product which meets the consumer’s requirements in terms of appearance, taste and texture (Alldrick, 2007).  In late 2003, Unilever innovated the bakery sector by introducing a white bread called Blue Band Goede Start, which was the first white bread containing the nutritional elements normally available in brown bread including fibers, vitamins B1, B3 and B6; iron; zinc; inulin, a starch that comes from wheat (Benkouider, 2005a).
  • 29.  It can be assumed that cholesterol-lowering spreads will gain increasing relevance in the coming years due to the market introduction of e.g. a functional variety of Becel1 margarine of Unilever (named ‘‘Becel pro-activ’’), containing phytostanol esters which are supposed to lower the cholesterol level.  Low-cholesterol butter under the trade name of BaladeTM has been produced and marketed in Belgium since 1992. In this case more than 90% of the cholesterol in milk fat has been removed by the addition of crystalline betacyclodextrin to the molten butter.  Other low-cholesterol milk products, like cheese, cream, or even low-cholesterol egg, are produced by this technology .
  • 30. Functional eggs  Eggs are of particular interest from a functionality point of view, because they are relatively rich in fatty acids and the associated fat-soluble compounds.  The idea of egg enrichment with omega-3 FAs simultaneously with antioxidants & other vitamins has recently been used to produce VITA eggs by Freshlay Foods (Devon, UK). They state that their eggs were enriched with omega-3 fatty acids, Se, vitamins D, E, B12 and folic acid.  Eggs enriched in omega-3 and vitamin E produced by Belovo under the trade name of Columbus first appeared in Belgium in 1997, and since then they have been sold in the UK (from 1998), The Netherlands (from 1999), India, Japan and South Africa (from 2000). Currently, production of Columbus egg exceeds 50 millions/year in Europe.  Similar eggs are produced by Pilgrim’s Pride Company, Gold Circle Farms and OmegaTech in the USA (Surai & Sparks, 2001).
  • 31. CONSUMER ACCEPTANCE OF FUNCTIONAL FOODS  socio-demographic characteristics, cognitive and attitudinal factors emerged as potential determinants  studies showed that consumer acceptance of functional foods is far from being unconditional, with one of the main conditions for acceptance pertaining to taste, besides trustworthiness of health claims. Although increasing the functionality of the food should not necessarily change its sensory quality (Urala & La¨hteenma¨ ki, 2004), bitter, acrid, astringent or salty off-flavours often inherently result from enhancing food functionality with bioactive compounds or plant-based phytonutrients.  most of these studies identified typical functional food consumer as being female, well educated, higher income class and older than 55.  Given the fact that prevention is a major motivation of use of functional food (Verbeke, 2006; Wrick, 1995), it can logically be hypothesized that experience with illnesses increases probabilities of functional food acceptance  Relatively high price can be regarded as one reason for the limited market success of several functional food products.
  • 32. Conclusion • Nutraceuticals & functional foods generate one of the most promising and dynamically developing segments of food industry. • Increasing consumer awareness in combination with new advances in various scientific domains is supporting the inflow of functional product. • In the case of a successful product development attention should be paid both to consumer demands and technical conditions, furthermore, the legislation background should not be neglected. Consumer acceptance is key success factor. • Consumer Acceptance, is determined by factors like primary health concerns, consumers’ familiarity with the ‘‘functional food’’ concepts and with the functional ingredients, the nature of the carrier product, the manner of health effect communication, etc. • Main conditions for acceptance of functional foods is pertaining to taste, besides, product quality, price, convenience and trustworthiness of health claims. • By purchasing functional foods in general consumers may achieve a modern and positive impression of themselves. These products provide consumers a modern way to follow a healthy lifestyle, which differs from the conventionally healthy diet defined by nutrition experts.